Cas:102029-47-0 lithium,[(2R,3S,4R,5R)-5-[6-(6-aminohexylamino)purin-9-yl]-4-hydroxy-3-phosphonooxyoxolan-2-yl]methyl hydrogen phosphate manufacturer & supplier

Chemical Name:lithium,[(2R,3S,4R,5R)-5-[6-(6-aminohexylamino)purin-9-yl]-4-hydroxy-3-phosphonooxyoxolan-2-yl]methyl hydrogen phosphate

CAS.NO:102029-47-0

Synonyms:N6-(6-Aminohexyl)adenosine 3 inverted exclamation marka,5 inverted exclamation marka-diphosphate lithium salt

Molecular Formula:C₁₆H₂₇LiN₆O₁₀P₂

Molecular Weight:532.30800

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:267.08000

Exact Mass:532.14200

LogP:0.81430

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like N6-(6-Aminohexyl)adenosine 3 inverted exclamation marka,5 inverted exclamation marka-diphosphate lithium salt chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,N6-(6-Aminohexyl)adenosine 3 inverted exclamation marka,5 inverted exclamation marka-diphosphate lithium salt physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,N6-(6-Aminohexyl)adenosine 3 inverted exclamation marka,5 inverted exclamation marka-diphosphate lithium salt Use and application,N6-(6-Aminohexyl)adenosine 3 inverted exclamation marka,5 inverted exclamation marka-diphosphate lithium salt technical grade,usp/ep/jp grade.

Related News: Biocatalytic processing offers many advantages over using conventional metal catalysts. The superior enantio- and regioselectivity of enzymes results in higher yields of purer product—typically comprising just a single enantiomer that has been modified on only a specific site. 4-[3-(methylthioureido)benzoyl]-1-methylpiperidine manufacturers Charles River Laboratories and AstraZeneca have maintained a strategic partnership since 2012, providing AstraZeneca with outsourced regulated safety and development support on a range of treatments and vaccines, including testing and facilitating the deployment of the vaccines Vaxzevria for COVID-19 and Fluenz for seasonal infleunza. methyl 3-[4-[(4-methylphenyl)sulfonylamino]phenyl]propanoate suppliers The FDA in announcing its approval noted that four, 12-week placebo-controlled clinical studies that included a total of 1,143 participants showed Nourianz offered a statistically significant decrease from baseline in daily “off” time compared to those on placebo. 1-ethyl-3,5-dinitro-hexahydro-[1,3,5]triazine vendor & factory.